We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Raymond James Financial
RJF
$33.8B
| $8.04M | 0.02% |
225,057
+2,190
| +1% | +$76.6K |
|
|
DNB
552
DELISTED
Dun & Bradstreet
DNB
| $8.01M | 0.02% |
68,206
-2,659
| -4% | -$305K |
|
553
Bio-Techne
TECH
$11.2B
| $7.99M | 0.02% |
341,404
-36,880
| -10% | -$864K |
|
|
RKT
554
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $7.98M | 0.02% |
167,748
+1,364
| +0.8% | +$67.7K |
|
555
Pinnacle West Capital
PNW
$12.2B
| $7.9M | 0.02% |
144,575
-3,164
| -2% | -$176K |
|
556
Pultegroup
PHM
$24.1B
| $7.81M | 0.02% |
442,320
-9,212
| -2% | -$174K |
|
557
Patterson-UTI
PTEN
$3.98B
| $7.78M | 0.02% |
239,023
+1,667
| +0.7% | +$56.6K |
|
558
Highwoods Properties
HIW
$3.65B
| $7.77M | 0.02% |
199,774
+4,920
| +3% | +$205K |
|
|
AMTD
559
DELISTED
TD Ameritrade Holding Corp
AMTD
| $7.74M | 0.02% |
231,886
+687
| +0.3% | +$22.2K |
|
560
Jones Lang LaSalle
JLL
$16.3B
| $7.73M | 0.02% |
61,206
+514
| +0.8% | +$66.9K |
|
|
PBCT
561
DELISTED
People's United Financial Inc
PBCT
| $7.71M | 0.02% |
533,075
-14,074
| -3% | -$209K |
|
562
Synopsys
SNPS
$74.4B
| $7.71M | 0.02% |
194,270
+5,830
| +3% | +$231K |
|
563
Camden Property Trust
CPT
$11B
| $7.71M | 0.02% |
112,450
-1,450
| -1% | -$105K |
|
|
OCR
564
DELISTED
OMNICARE INC
OCR
| $7.66M | 0.02% |
122,972
+520
| +0.4% | +$33.1K |
|
565
Broadridge
BR
$17.8B
| $7.62M | 0.02% |
182,940
-65,473
| -26% | -$2.72M |
|
|
LHO
566
DELISTED
LaSalle Hotel Properties
LHO
| $7.59M | 0.02% |
221,646
+52,660
| +31% | +$1.88M |
|
|
DNR
567
DELISTED
Denbury Resources, Inc.
DNR
| $7.57M | 0.02% |
503,527
-6,839
| -1% | -$115K |
|
|
AVP
568
DELISTED
Avon Products, Inc.
AVP
| $7.55M | 0.02% |
599,367
-14,674
| -2% | -$201K |
|
|
ESL
569
DELISTED
Esterline Technologies
ESL
| $7.55M | 0.02% |
67,836
+1,776
| +3% | +$202K |
|
570
Lincoln Electric
LECO
$14.2B
| $7.54M | 0.02% |
109,027
+617
| +0.6% | +$42.9K |
|
571
Pitney Bowes
PBI
$2.4B
| $7.53M | 0.02% |
301,463
-11,680
| -4% | -$312K |
|
572
Jacobs Solutions
J
$15.9B
| $7.48M | 0.02% |
185,163
-5,204
| -3% | -$227K |
|
573
Alliant Energy
LNT
$18.3B
| $7.47M | 0.02% |
269,660
+1,500
| +0.6% | +$43.3K |
|
574
Tenet Healthcare
THC
$20.5B
| $7.47M | 0.02% |
125,746
-3,583
| -3% | -$200K |
|
575
iShares Russell 1000 ETF
IWB
$48.2B
| $7.45M | 0.02% |
67,810
+57,510
| +558% | +$6.36M |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.